報告摘要

The global OTC Anti-Infective Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032. North America: the OTC Anti-Infective Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the OTC Anti-Infective Drug market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the OTC Anti-Infective Drug market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of OTC Anti-Infective Drug include Cipla, CR SANJIU, Lingrui, Sun Pharma, Bayer, GSK, MYLAN, NOVARTIS and Johnson & Johnson and among others; in 2025, the top three vendors together accounted for approximately % of global revenue. Report Scope This report quantifies the global OTC Anti-Infective Drug market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032. It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to OTC Anti-Infective Drug. Key Companies & Market Share Insights This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking. OTC Anti-Infective Drug Market by Company Cipla CR SANJIU Lingrui Sun Pharma Bayer GSK MYLAN NOVARTIS Johnson & Johnson Teva OTC Anti-Infective Drug Segment by Type Antiviral Antibacterial Antifungal Antiseptics Other OTC Anti-Infective Drug Segment by Application Retail Pharmacies Online Pharmacies Hospital Pharmacies OTC Anti-Infective Drug Segment by Region North America United States Canada Europe Germany France U.K. Italy Spain Russia Netherlands Nordic Countries Asia-Pacific China Japan South Korea India Australia China Taiwan Southeast Asia South America Mexico Brazil Argentina Middle East & Africa Saudi Arabia Israel United Arab Emirates Turkey Iran Egypt Key Drivers & Barriers High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects. Reasons to Buy This Report 1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Anti-Infective Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market. 2. This report will help stakeholders to understand the global industry status and trends of OTC Anti-Infective Drug and provides them with information on key market drivers, restraints, challenges, and opportunities. 3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition. 4. This report stays updated with novel technology integration, features, and the latest developments in the market 5. This report helps stakeholders to gain insights into which regions to target globally 6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Anti-Infective Drug. 7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution. Chapter Outline Chapter 1: Research objectives, research methods, data sources, data cross-validation; Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term. Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry. Chapter 6: Detailed analysis of OTC Anti-Infective Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc. Chapter 13: The main points and conclusions of the report.

目錄 Table of Contents

1 Preface 1.1 Scope of Report 1.2 Reasons for Doing This Study 1.3 Research Methodology 1.4 Research Process 1.5 Data Source 1.5.1 Secondary Sources 1.5.2 Primary Sources 2 Market Overview 2.1 Product Definition 2.2 OTC Anti-Infective Drug by Type 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) 2.2.2 Antiviral 2.2.3 Antibacterial 2.2.4 Antifungal 2.2.5 Antiseptics 2.2.6 Other 2.3 OTC Anti-Infective Drug by Application 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) 2.3.2 Retail Pharmacies 2.3.3 Online Pharmacies 2.3.4 Hospital Pharmacies 2.4 Assumptions and Limitations 3 OTC Anti-Infective Drug Breakdown Data by Type 3.1 Global OTC Anti-Infective Drug Historic Market Size by Type (2021-2026) 3.2 Global OTC Anti-Infective Drug Forecasted Market Size by Type (2027-2032) 4 OTC Anti-Infective Drug Breakdown Data by Application 4.1 Global OTC Anti-Infective Drug Historic Market Size by Application (2021-2026) 4.2 Global OTC Anti-Infective Drug Forecasted Market Size by Application (2027-2032) 5 Global Growth Trends 5.1 Global OTC Anti-Infective Drug Market Perspective (2021-2032) 5.2 Global OTC Anti-Infective Drug Growth Trends by Region 5.2.1 Global OTC Anti-Infective Drug Market Size by Region: 2021 VS 2025 VS 2032 5.2.2 OTC Anti-Infective Drug Historic Market Size by Region (2021-2026) 5.2.3 OTC Anti-Infective Drug Forecasted Market Size by Region (2027-2032) 5.3 OTC Anti-Infective Drug Market Dynamics 5.3.1 OTC Anti-Infective Drug Industry Trends 5.3.2 OTC Anti-Infective Drug Market Drivers 5.3.3 OTC Anti-Infective Drug Market Challenges 5.3.4 OTC Anti-Infective Drug Market Restraints 6 Market Competitive Landscape by Players 6.1 Global Top OTC Anti-Infective Drug Players by Revenue 6.1.1 Global Top OTC Anti-Infective Drug Players by Revenue (2021-2026) 6.1.2 Global OTC Anti-Infective Drug Revenue Market Share by Players (2021-2026) 6.2 Global OTC Anti-Infective Drug Industry Players Ranking, 2023 VS 2024 VS 2025 6.3 Global Key Players of OTC Anti-Infective Drug Head Office and Area Served 6.4 Global OTC Anti-Infective Drug Players, Product Type & Application 6.5 Global OTC Anti-Infective Drug Manufacturers Established Date 6.6 Global OTC Anti-Infective Drug Market CR5 and HHI 6.7 Global Players Mergers & Acquisition 7 North America 7.1 North America OTC Anti-Infective Drug Market Size (2021-2032) 7.2 North America OTC Anti-Infective Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032 7.3 North America OTC Anti-Infective Drug Market Size by Country (2021-2026) 7.4 North America OTC Anti-Infective Drug Market Size by Country (2027-2032) 7.5 United States 7.5 United States 7.6 Canada 7.7 Mexico 8 Europe 8.1 Europe OTC Anti-Infective Drug Market Size (2021-2032) 8.2 Europe OTC Anti-Infective Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032 8.3 Europe OTC Anti-Infective Drug Market Size by Country (2021-2026) 8.4 Europe OTC Anti-Infective Drug Market Size by Country (2027-2032) 8.5 Germany 8.6 France 8.7 U.K. 8.8 Italy 8.9 Spain 8.10 Russia 8.11 Netherlands 8.12 Nordic Countries 9 Asia-Pacific 9.1 Asia-Pacific OTC Anti-Infective Drug Market Size (2021-2032) 9.2 Asia-Pacific OTC Anti-Infective Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032 9.3 Asia-Pacific OTC Anti-Infective Drug Market Size by Country (2021-2026) 9.4 Asia-Pacific OTC Anti-Infective Drug Market Size by Country (2027-2032) 9.5 China 9.6 Japan 9.7 South Korea 9.8 India 9.9 Australia 9.10 China Taiwan 9.11 Southeast Asia 10 South America 10.1 South America OTC Anti-Infective Drug Market Size (2021-2032) 10.2 South America OTC Anti-Infective Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032 10.3 South America OTC Anti-Infective Drug Market Size by Country (2021-2026) 10.4 South America OTC Anti-Infective Drug Market Size by Country (2027-2032) 10.5 Brazil 10.6 Argentina 10.7 Chile 10.8 Colombia 10.9 Peru 11 Middle East & Africa 11.1 Middle East & Africa OTC Anti-Infective Drug Market Size (2021-2032) 11.2 Middle East & Africa OTC Anti-Infective Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032 11.3 Middle East & Africa OTC Anti-Infective Drug Market Size by Country (2021-2026) 11.4 Middle East & Africa OTC Anti-Infective Drug Market Size by Country (2027-2032) 11.5 Saudi Arabia 11.6 Israel 11.7 United Arab Emirates 11.8 Turkey 11.9 Iran 11.10 Egypt 12 Players Profiled 12.1 Cipla 12.1.1 Cipla Company Information 12.1.2 Cipla Business Overview 12.1.3 Cipla Revenue in OTC Anti-Infective Drug Business (2021-2026) 12.1.4 Cipla OTC Anti-Infective Drug Product Portfolio 12.1.5 Cipla Recent Developments 12.2 CR SANJIU 12.2.1 CR SANJIU Company Information 12.2.2 CR SANJIU Business Overview 12.2.3 CR SANJIU Revenue in OTC Anti-Infective Drug Business (2021-2026) 12.2.4 CR SANJIU OTC Anti-Infective Drug Product Portfolio 12.2.5 CR SANJIU Recent Developments 12.3 Lingrui 12.3.1 Lingrui Company Information 12.3.2 Lingrui Business Overview 12.3.3 Lingrui Revenue in OTC Anti-Infective Drug Business (2021-2026) 12.3.4 Lingrui OTC Anti-Infective Drug Product Portfolio 12.3.5 Lingrui Recent Developments 12.4 Sun Pharma 12.4.1 Sun Pharma Company Information 12.4.2 Sun Pharma Business Overview 12.4.3 Sun Pharma Revenue in OTC Anti-Infective Drug Business (2021-2026) 12.4.4 Sun Pharma OTC Anti-Infective Drug Product Portfolio 12.4.5 Sun Pharma Recent Developments 12.5 Bayer 12.5.1 Bayer Company Information 12.5.2 Bayer Business Overview 12.5.3 Bayer Revenue in OTC Anti-Infective Drug Business (2021-2026) 12.5.4 Bayer OTC Anti-Infective Drug Product Portfolio 12.5.5 Bayer Recent Developments 12.6 GSK 12.6.1 GSK Company Information 12.6.2 GSK Business Overview 12.6.3 GSK Revenue in OTC Anti-Infective Drug Business (2021-2026) 12.6.4 GSK OTC Anti-Infective Drug Product Portfolio 12.6.5 GSK Recent Developments 12.7 MYLAN 12.7.1 MYLAN Company Information 12.7.2 MYLAN Business Overview 12.7.3 MYLAN Revenue in OTC Anti-Infective Drug Business (2021-2026) 12.7.4 MYLAN OTC Anti-Infective Drug Product Portfolio 12.7.5 MYLAN Recent Developments 12.8 NOVARTIS 12.8.1 NOVARTIS Company Information 12.8.2 NOVARTIS Business Overview 12.8.3 NOVARTIS Revenue in OTC Anti-Infective Drug Business (2021-2026) 12.8.4 NOVARTIS OTC Anti-Infective Drug Product Portfolio 12.8.5 NOVARTIS Recent Developments 12.9 Johnson & Johnson 12.9.1 Johnson & Johnson Company Information 12.9.2 Johnson & Johnson Business Overview 12.9.3 Johnson & Johnson Revenue in OTC Anti-Infective Drug Business (2021-2026) 12.9.4 Johnson & Johnson OTC Anti-Infective Drug Product Portfolio 12.9.5 Johnson & Johnson Recent Developments 12.10 Teva 12.10.1 Teva Company Information 12.10.2 Teva Business Overview 12.10.3 Teva Revenue in OTC Anti-Infective Drug Business (2021-2026) 12.10.4 Teva OTC Anti-Infective Drug Product Portfolio 12.10.5 Teva Recent Developments 13 Report Conclusion 14 Disclaimer

圖表清單 List of Tables & Figures

List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global OTC Anti-Infective Drug Market Size by Type (2021-2026) & (US$ Million) Table 6. Global OTC Anti-Infective Drug Revenue Market Share by Type (2021-2026) Table 7. Global OTC Anti-Infective Drug Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global OTC Anti-Infective Drug Revenue Market Share by Type (2027-2032) Table 9. Global OTC Anti-Infective Drug Market Size by Application (2021-2026) & (US$ Million) Table 10. Global OTC Anti-Infective Drug Revenue Market Share by Application (2021-2026) Table 11. Global OTC Anti-Infective Drug Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global OTC Anti-Infective Drug Revenue Market Share by Application (2027-2032) Table 13. Global OTC Anti-Infective Drug Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global OTC Anti-Infective Drug Market Size by Region (2021-2026) & (US$ Million) Table 15. Global OTC Anti-Infective Drug Market Share by Region (2021-2026) Table 16. Global OTC Anti-Infective Drug Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global OTC Anti-Infective Drug Market Share by Region (2027-2032) Table 18. OTC Anti-Infective Drug Industry Trends Table 19. OTC Anti-Infective Drug Industry Drivers Table 20. OTC Anti-Infective Drug Industry Opportunities and Challenges Table 21. OTC Anti-Infective Drug Market Restraints Table 22. Global Top OTC Anti-Infective Drug Players by Revenue (US$ Million) & (2021-2026) Table 23. Global OTC Anti-Infective Drug Revenue Market Share by Players (2021-2026) Table 24. Global OTC Anti-Infective Drug Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of OTC Anti-Infective Drug, Headquarters and Area Served Table 26. Global OTC Anti-Infective Drug Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global OTC Anti-Infective Drug by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America OTC Anti-Infective Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America OTC Anti-Infective Drug Market Size by Country (2021-2026) & (US$ Million) Table 32. North America OTC Anti-Infective Drug Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe OTC Anti-Infective Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe OTC Anti-Infective Drug Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe OTC Anti-Infective Drug Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific OTC Anti-Infective Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific OTC Anti-Infective Drug Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific OTC Anti-Infective Drug Market Size by Country (2027-2032) & (US$ Million) Table 39. South America OTC Anti-Infective Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America OTC Anti-Infective Drug Market Size by Country (2021-2026) & (US$ Million) Table 41. South America OTC Anti-Infective Drug Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa OTC Anti-Infective Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa OTC Anti-Infective Drug Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa OTC Anti-Infective Drug Market Size by Country (2027-2032) & (US$ Million) Table 45. Cipla Company Information Table 46. Cipla Business Overview Table 47. Cipla Revenue in OTC Anti-Infective Drug Business (2021-2026) & (US$ Million) Table 48. Cipla OTC Anti-Infective Drug Product Portfolio Table 49. Cipla Recent Developments Table 50. CR SANJIU Company Information Table 51. CR SANJIU Business Overview Table 52. CR SANJIU Revenue in OTC Anti-Infective Drug Business (2021-2026) & (US$ Million) Table 53. CR SANJIU OTC Anti-Infective Drug Product Portfolio Table 54. CR SANJIU Recent Developments Table 55. Lingrui Company Information Table 56. Lingrui Business Overview Table 57. Lingrui Revenue in OTC Anti-Infective Drug Business (2021-2026) & (US$ Million) Table 58. Lingrui OTC Anti-Infective Drug Product Portfolio Table 59. Lingrui Recent Developments Table 60. Sun Pharma Company Information Table 61. Sun Pharma Business Overview Table 62. Sun Pharma Revenue in OTC Anti-Infective Drug Business (2021-2026) & (US$ Million) Table 63. Sun Pharma OTC Anti-Infective Drug Product Portfolio Table 64. Sun Pharma Recent Developments Table 65. Bayer Company Information Table 66. Bayer Business Overview Table 67. Bayer Revenue in OTC Anti-Infective Drug Business (2021-2026) & (US$ Million) Table 68. Bayer OTC Anti-Infective Drug Product Portfolio Table 69. Bayer Recent Developments Table 70. GSK Company Information Table 71. GSK Business Overview Table 72. GSK Revenue in OTC Anti-Infective Drug Business (2021-2026) & (US$ Million) Table 73. GSK OTC Anti-Infective Drug Product Portfolio Table 74. GSK Recent Developments Table 75. MYLAN Company Information Table 76. MYLAN Business Overview Table 77. MYLAN Revenue in OTC Anti-Infective Drug Business (2021-2026) & (US$ Million) Table 78. MYLAN OTC Anti-Infective Drug Product Portfolio Table 79. MYLAN Recent Developments Table 80. NOVARTIS Company Information Table 81. NOVARTIS Business Overview Table 82. NOVARTIS Revenue in OTC Anti-Infective Drug Business (2021-2026) & (US$ Million) Table 83. NOVARTIS OTC Anti-Infective Drug Product Portfolio Table 84. NOVARTIS Recent Developments Table 85. Johnson & Johnson Company Information Table 86. Johnson & Johnson Business Overview Table 87. Johnson & Johnson Revenue in OTC Anti-Infective Drug Business (2021-2026) & (US$ Million) Table 88. Johnson & Johnson OTC Anti-Infective Drug Product Portfolio Table 89. Johnson & Johnson Recent Developments Table 90. Teva Company Information Table 91. Teva Business Overview Table 92. Teva Revenue in OTC Anti-Infective Drug Business (2021-2026) & (US$ Million) Table 93. Teva OTC Anti-Infective Drug Product Portfolio Table 94. Teva Recent Developments Table 95. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. OTC Anti-Infective Drug Product Image Figure 5. Global OTC Anti-Infective Drug Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global OTC Anti-Infective Drug Market Share by Type: 2025 VS 2032 Figure 7. Antiviral Product Figure 8. Antibacterial Product Figure 9. Antifungal Product Figure 10. Antiseptics Product Figure 11. Other Product Figure 12. Global OTC Anti-Infective Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global OTC Anti-Infective Drug Market Share by Application: 2025 VS 2032 Figure 14. Retail Pharmacies Product Figure 15. Online Pharmacies Product Figure 16. Hospital Pharmacies Product Figure 17. Global OTC Anti-Infective Drug Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 18. Global OTC Anti-Infective Drug Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global OTC Anti-Infective Drug Market Share by Region: 2025 VS 2032 Figure 20. Global OTC Anti-Infective Drug Market Share by Players in 2025 Figure 21. Global OTC Anti-Infective Drug Manufacturers Established Date Figure 22. Global Top 5 and 10 OTC Anti-Infective Drug Players Market Share by Revenue in 2025 Figure 23. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 24. North America OTC Anti-Infective Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. North America OTC Anti-Infective Drug Market Share by Country (2021-2032) Figure 26. United States OTC Anti-Infective Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Canada OTC Anti-Infective Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 28. Mexico OTC Anti-Infective Drug Market Share by Country (2021-2032) Figure 29. Europe OTC Anti-Infective Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe OTC Anti-Infective Drug Market Share by Country (2021-2032) Figure 31. Germany OTC Anti-Infective Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. France OTC Anti-Infective Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. U.K. OTC Anti-Infective Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Italy OTC Anti-Infective Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Spain OTC Anti-Infective Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Russia OTC Anti-Infective Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Netherlands OTC Anti-Infective Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Nordic Countries OTC Anti-Infective Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Asia-Pacific OTC Anti-Infective Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. Asia-Pacific OTC Anti-Infective Drug Market Share by Country (2021-2032) Figure 41. China OTC Anti-Infective Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. Japan OTC Anti-Infective Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. South Korea OTC Anti-Infective Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. India OTC Anti-Infective Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. India OTC Anti-Infective Drug Market Share by Country (2021-2032) Figure 46. Australia OTC Anti-Infective Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. China Taiwan OTC Anti-Infective Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. Southeast Asia OTC Anti-Infective Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. South America OTC Anti-Infective Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. South America OTC Anti-Infective Drug Market Share by Country (2021-2032) Figure 51. Brazil OTC Anti-Infective Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Argentina OTC Anti-Infective Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Chile OTC Anti-Infective Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. Colombia OTC Anti-Infective Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 55. Peru OTC Anti-Infective Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 56. Cipla Revenue Growth Rate in OTC Anti-Infective Drug Business (2021-2026) Figure 57. CR SANJIU Revenue Growth Rate in OTC Anti-Infective Drug Business (2021-2026) Figure 58. Lingrui Revenue Growth Rate in OTC Anti-Infective Drug Business (2021-2026) Figure 59. Sun Pharma Revenue Growth Rate in OTC Anti-Infective Drug Business (2021-2026) Figure 60. Bayer Revenue Growth Rate in OTC Anti-Infective Drug Business (2021-2026) Figure 61. GSK Revenue Growth Rate in OTC Anti-Infective Drug Business (2021-2026) Figure 62. MYLAN Revenue Growth Rate in OTC Anti-Infective Drug Business (2021-2026) Figure 63. NOVARTIS Revenue Growth Rate in OTC Anti-Infective Drug Business (2021-2026) Figure 64. Johnson & Johnson Revenue Growth Rate in OTC Anti-Infective Drug Business (2021-2026) Figure 65. Teva Revenue Growth Rate in OTC Anti-Infective Drug Business (2021-2026)

Single User	$2,950 USD
Multi User	$4,430 USD
Enterprise	$5,900 USD

OTC Anti-Infective Drug Industry Research Report 2026

授權報價

報告摘要

提及公司